Clinical Impact of New Rheumatoid Arthritis Findings From ACR/ARP 2020*

Download All
November 5-9, 2020; Virtual Meeting
Review the latest RA management data with Capsule Summaries and expert-authored commentaries covering key studies from ACR/ARP 2020.
Maria Danila, MD, MSc, MSPH
Jonathan Kay, MD
William F. C. Rigby, MD

Highlights

Slidesets Immunogenicity of Adjuvanted Herpes Zoster Subunit Vaccine in Patients With RA Treated With JAK Inhibitors vs Controls
Slidesets Lack of Association Between Hydroxychloroquine and Cardiac Events in Patients With RA
Slidesets Use of a Pharmacogenomics-Driven Machine Learning Approach to Predict Patient Response to Methotrexate
Slidesets ARCTIC REWIND: Tapering and Withdrawing TNF Inhibitor Associated With Higher Flare Risk in Patients With RA in Stable Remission
Slidesets SELECT Pooled Analysis: Incidence and Risk Factors for VTE in Patients With RA Treated With Upadacitinib
Slidesets MONARCH vs MOBILITY: Similar Efficacy With Sarilumab ± MTX in MTX-IR/INT RA
Slidesets Pooled Analysis of Filgotinib Trials in RA: Incidence and Risk Factors for VTE and MACE
Slidesets In Multicohort Dutch Study, Most Arthralgia Patients With Subclinical Synovitis Did Not Progress to Inflammatory Arthritis After 3 Yrs
Slidesets CATCH/CATCH-US Pooled Analysis: Comparison Between Clinician-Assessed vs Patient-Reported CDAI in Patients With Early RA in Telemedicine
Slidesets SEAM-RA: Maintenance of Remission Better After Withdrawal of Methotrexate Than Withdrawal of Etanercept

Two key studies from ACR/ARP 2020 shed new light on our use of IL-6 inhibitors, including tocilizumab and sarilumab.

William F. C. Rigby, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 4, 2020 Expired: December 3, 2021

Two key studies from ACR/ARP 2020 shed new light on the best approach to tapering therapy during RA remission.

Jonathan Kay, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 18, 2020 Expired: December 17, 2021

New studies from ACR/ARP 2020 add to our understanding of cardiovascular safety with several RA therapeutics and demonstrate effectiveness of herpes zoster vaccination in patients with RA.

Maria Danila, MD, MSc, MSPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 18, 2020 Expired: December 17, 2021

When is a rheumatoid really a rheumatoid, and what are the implications for telemedicine?

Jonathan Kay, MD William F. C. Rigby, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 18, 2020 Expired: December 17, 2021
Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie Inc.
Gilead Sciences, Inc.
Sanofi Genzyme Corporation

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue